Skip to main content
. 2016 Mar 31;3(3):177–188. doi: 10.1002/ehf2.12088

Table 2.

Oral medications on admission

  Furosemide (n = 30) Tolvaptan (n = 30) P‐value
Furosemide 13 (43%) 14 (47%) 0.79
Dose, mg/day 20 (20–40) 40 (20–40) 0.61
Aldosterone antagonist 7 (23%) 9 (30%) 0.56
Thiazide 1 (3%) 2 (7%) 0.55
Digoxin 3 (10%) 4 (13%) 0.69
β blocker 12 (40%) 12 (40%) 1.00
ACE inhibitor 2 (7%) 4 (13%) 0.39
ARB 10 (33%) 9 (30%) 0.78
Calcium channel blocker 13 (43%) 10 (33%) 0.43
ISDN 4 (13%) 4 (13%) 1.00
Statin 10 (33%) 5 (17%) 0.14

ACE: angiotensin converting enzyme; ARB: angiotensin II receptor blocker; ISDN: isosorbide dinitrate.

Data presented as number (%), or median with interquartile range.